Bayer Confirms Postponed Glyphosate Trial
October 07 2019 - 6:03AM
Dow Jones News
By Kim Richters
Germany's Bayer AG (BAYN.XE) confirmed on Monday that a U.S.
trial relating to Monsanto's glyphosate-based herbicide Roundup has
been postponed to next year.
The trial, originally scheduled for Oct. 15 in St. Louis,
Missouri, where Monsanto is headquartered, has now been moved to
next year, Bayer said. There are no further trials scheduled for
2019, it said.
German newspaper Handelsblatt first reported the rescheduling on
Sunday.
Bayer has faced significant legal challenges since taking over
Monsanto last year, with lawsuits from around 18,400 plaintiffs in
the U.S. as of July 11. Among the lawsuits are claims that
Monsanto's glyphosate-based Roundup could cause cancer.
Bayer will update the plaintiff figure on Oct. 30, when it
reports third-quarter results, it said.
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
October 07, 2019 05:48 ET (09:48 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Bayer (TG:BAYN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bayer (TG:BAYN)
Historical Stock Chart
From Apr 2023 to Apr 2024
